Travere Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Audio By Carbonatix

SAN DIEGO--(BUSINESS WIRE)--Jan 5, 2026--

Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Eric Dube, Ph.D., president and chief executive officer, will present at the 44 th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 4:30 p.m. PT.

A live webcast of the presentation will be accessible on the Investor page of Travere’s website at ir.travere.com/events-presentations, and a replay will be available for up to 30 days following the event.

About Travere Therapeutics

At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope �� today and tomorrow. For more information, visit travere.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20260105406739/en/

CONTACT: Investors:

888-969-7879

IR@travere.comMedia:

888-969-7879

mediarelations@travere.com

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH SCIENCE PHARMACEUTICAL RESEARCH

SOURCE: Travere Therapeutics, Inc.

Copyright Business Wire 2026.

PUB: 01/05/2026 04:30 PM/DISC: 01/05/2026 04:30 PM

http://www.businesswire.com/news/home/20260105406739/en